Stryker Corp
NYSE:SYK
Stryker Corp
NYSE:SYK
Price:
324.3 USD
-0.08%
Market Closed
Updated:
May 15, 2024
EV/S
Enterprise Value to Sales
Enterprise Value to Sales
6.3
Current
6.3
Median
2.5
Industry
Higher
than median
Higher
than industry value
Enterprise Value to Sales (EV/S) ratio is a valuation multiple that compares the enterprise value (EV) of a company to its revenues. The EV/S multiple gives investors a quantifiable metric of how to value a company based on its sales while taking account of both the company's equity and debt.
EV/S
=6.3
Enterprise Value
/
131.9B
Revenue
21B
All Countries
| Market Cap | EV/S | ||||
|---|---|---|---|---|---|
| US |
|
Stryker Corp
NYSE:SYK
|
123.5B USD | 6.3 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
180.9B USD | 4.6 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
136.3B USD | 17.9 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
112.1B USD | 4 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
108B USD | 7.8 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
67.9B USD | 4.1 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
59.1B EUR | 3.2 | |
| CN |
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
378.2B CNY | 10 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
52B USD | 8.3 | |
| US |
|
Dexcom Inc
NASDAQ:DXCM
|
49.9B USD | 13 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
43.2B USD | 11.7 |
EV/S Forward Multiples
Forward EV/S multiple is a version of the EV/S ratio that uses forecasted revenue for the EV/S calculation. 1-Year, 2-Years, and 3-Years forwards use revenue forecasts for 1, 2, and 3 years ahead, respectively.
1-Year Forward
EV/S
5.9
2-Years Forward
EV/S
5.5
3-Years Forward
EV/S
5.1
You don't have any saved screeners yet
